Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT01962792 · COMPLETED
Trial details
- NCT number
- NCT01962792
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2019-03-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.